Dr. May Alattar, MD

Dr. Alattar practices at Telemed2U in Apple Valley, California.

Dr. Alattar's NPI, 1154523371, was assigned on June 1, 2007. Dr. Alattar graduated from University of Al-Mustansiriyah College of Medicine in 1999. Dr. Alattar holds Maryland license D68860.

Dr. Alattar's primary practice is Telemed2U, at 18564 Us-18, Apple Valley, CA 92307 in San Bernardino County. The practice phone is (916) 740-3721.

Dr. Alattar's primary practice is Telemed2U in Apple Valley, California. Dr. Alattar is also affiliated with Sibley Memorial Hospital. The medical group on file is TeleMed2U. Dmand AI also links Dr. Alattar to 2 more hospitals, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alattar practices, 5 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Alattar's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Alattar is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Alattar's licenses on file in 5 states: Maryland, District of Columbia, California, Kentucky and Virginia.

Dmand AI lists chronic diabetes and diabetic emergency among the conditions Dr. Alattar treats.

CMS data shows 214 Medicare services from Dr. Alattar across 4 procedure codes in 2024, for 160 Medicare patients. Medicare paid $18,152 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Alattar in 2024. The largest group is 75 to 84, with 64 patients. 75% of them have diabetes, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alattar's median patient age at 49, with 39% women.

In 2024, Dr. Alattar wrote 114 Medicare Part D claims for 47 patients. Every claim was for a generic drug. CMS names the drug for 24 of them, across 1 drug with 11 or more claims each, at $32,242 in total drug cost. In 2023, CMS named 257 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Alattar for performance year 2024, reported as part of a group. Dr. Alattar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alattar as offering telehealth.

Dmand AI links 7 papers to Dr. Alattar, published from 2013 to 2020. 2020 was the busiest year, with 2. The most frequent topics are Dipeptidyl-Peptidase IV Inhibitors, Exenatide and Glucagon-Like Peptide 1. Dr. Alattar's most frequent co-authors are Talha Ahmed, MD, Kristina Ingeborg Rother, MD and Gayatri Sarkar, MD.

CMS Open Payments shows 15 general payments to Dr. Alattar from 11 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 89% of the total. Dexcom, Inc. paid the most, $264.

Dr. Alattar graduated from University of Al-Mustansiriyah College of Medicine in 1999. Dr. Alattar is a member of AACE and ENDO.

Dr. Alattar is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CareFirst BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.